Yuichi Iwaki
2021
In 2021, Yuichi Iwaki earned a total compensation of $2.8M as President and Chief Executive Officer at MediciNova, a 7% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $163,987 |
|---|---|
| Option Awards | $1,980,330 |
| Salary | $596,315 |
| Other | $17,400 |
| Total | $2,758,032 |
Iwaki received $2M in option awards, accounting for 72% of the total pay in 2021.
Iwaki also received $164K in non-equity incentive plan, $596.3K in salary and $17.4K in other compensation.
Rankings
In 2021, Yuichi Iwaki's compensation ranked 4,765th out of 12,406 executives tracked by ExecPay. In other words, Iwaki earned more than 61.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,765 out of 12,406 | 62nd |
Division Manufacturing | 1,982 out of 5,494 | 64th |
Major group Chemicals And Allied Products | 833 out of 2,369 | 65th |
Industry group Drugs | 745 out of 2,090 | 64th |
Industry Pharmaceutical Preparations | 533 out of 1,537 | 65th |
Source: SEC filing on April 26, 2022.
Iwaki's colleagues
We found two more compensation records of executives who worked with Yuichi Iwaki at MediciNova in 2021.